South Africa
South Africa's efforts to produce vaccines are key to helping the African continent become more self-sufficient in inoculations to combat COVID-19 and many other diseases, the visiting chief of the World Health Organization said Friday.
WHO director-general Dr. Tedros Ghebreyesus was visiting Cape Town to view three facilities that are starting work to manufacture vaccines.
"More than half of the world's population is now fully vaccinated, and yet 84% of the population of Africa is yet to receive a single dose," Tedros said during a press briefing.
Tedros added there was an "urgent need" to increase local production of vaccines in low and middle-income countries.
He was also scheduled to visit the Afrigen lab that, with support from the WHO, is creating a COVID-19 vaccine from scratch.
The laboratory is replicating the Moderna vaccine using mRNA vaccine technology.
The Afrigen facility has backing from WHO and several other partners including the governments of South Africa, France and Belgium.
The initiative is also supported by the Africa Centers for Disease Control and Prevention.
Tedros said it is expected that clinical trials for the vaccine candidate developed by Afrigen would start in 2022 and it is hoped that approval for its use will be granted in 2024.
Go to video
Tanzania bans agricultural imports from South Africa and Malawi
Go to video
Immunization at risk: Global health leaders urge action amid rising disease outbreaks
Go to video
South Africa's tax row heads to court as implementation date nears
01:02
WHO member countries draft landmark preparedness treaty for next pandemic
Go to video
South Africa appoints Mcebisi Jonas as special US envoy in bid to ease tensions
Go to video
South Africa: inquest into death of Nobel Peace Prize laureate Chief Albert Luthuli re-opened